ALBANY, N.Y., March 27, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 third quarter financial results on Monday, April 8, 2013, after the close of the U.S. financial markets.
Management will host a conference call to discuss the results and answer questions beginning at 4:30 p.m. Eastern Time on April 8, 2013. To participate in the live call by telephone, please dial 1-877-941-8609.
A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. To listen to the live webcast, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact: AngioDynamics, Inc. Mark Frost, CFO (800) 772-6446 x1981 mfrost@AngioDynamics.com Investor Relations Contacts: EVC Group, Inc. Greg Gin/Robert Jones (646) 445-4801; (646) 201-5447 email@example.com; firstname.lastname@example.org Media Contact: EVC Group, Inc. Chris Gale (646) 201-5431 email@example.comSource:AngioDynamics